Navigation Links
Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences
Date:1/20/2009

PHILADELPHIA, Jan. 20 /PRNewswire/ -- Mealey's Conferences (now HB Litigation Conferences) released its upcoming schedule of CLE accredited teleconferences for tort litigators, plus a professional development opportunity for women in the legal profession.

     Upcoming teleconferences include:

     January 22 - Asbestos Gaskets: Exposure and the State of the Art.

     February 5 - Duragesic/Fentanyl Patch.

February 5 - Nanotechnology: Is it the Next Plastics or the Next Asbestos?

February 23 - Hot Topics in Pharma Litigation: Byetta, Digitek, Yasmin, NuvaRing & More.

February 24 - Defense Perspectives on Attorney General Pharmaceutical Claims.

February 24 - Construction Defect Litigation: Delay, Disruption, Collection Claims in Foreclosure & Contract Disputes.

February 26 - International Asbestos Litigation.

February 12 - Effective Negotiating Skills for Women Lawyers (CLE depends on state bar rules).

Not only can attorneys use these programs to educate practice teams, but can benefit from 2-for-1 pricing (promo code MASSTORTS141 required).

Interested attorneys are encouraged to visit http://www.LitigationConferences.com for more info, plus free articles and audio/video clips from the company's archives covering insurance, reinsurance, toxic torts, construction litigation and complex commercial and financial litigation. Recent audio posts include one of plaintiff attorney Mark Lanier speaking on asbestos last year. New video posts, more than a dozen, are available from last week's banking litigation conference.

    Call us at 484-324-2755 x200.  Email
Kathleen.McFadden@litigationconferences.com or
Lynnsey.PerrinHee@litigationconferences.com.

Teleconferences are accredited for 1.5CLEs and take place from 2pm-3:40pm EST except where noted.

HB Litigation Conferences, fka Mealey's Conferences, is a leading provider of litigation conferences, seminars, and teleconferences with a rich archive of legal education materials and multimedia content. All programs are fully accredited for continuing legal education. For general inquiries write to info@litigationconferences.com.

     CONTACT
     Lynnsey Perrin Hee
     HB Litigation Conferences
     fka Mealey's Conferences
     lynnsey.perrinhee@litigationconferences.com
    (484) 324-2755 x210

'/>"/>
SOURCE HB Litigation Conferences: fka Mealey's Conferences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology:
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
Breaking Biology News(10 mins):